Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
OrthoPediatrics ( (KIDS) ) has issued an update.
On August 5, 2025, OrthoPediatrics Corp. announced the expansion of its OrthoPediatrics Specialty Bracing (OPSB) division with new clinics and entry into new territories, including California, Ohio, Colorado, New York, and Ireland. This strategic expansion aims to enhance access to pediatric orthopedic care, leveraging partnerships with major children’s hospitals and expanding into international markets, thereby positioning the company to meet the growing demand for pediatric bracing and orthopedic care.
The most recent analyst rating on (KIDS) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on OrthoPediatrics stock, see the KIDS Stock Forecast page.
Spark’s Take on KIDS Stock
According to Spark, TipRanks’ AI Analyst, KIDS is a Neutral.
OrthoPediatrics shows strong potential with significant revenue growth and a positive outlook from recent earnings calls. However, profitability challenges and negative cash flows weigh down the overall score. Technical indicators suggest a neutral stance, while corporate events and strategic initiatives provide optimism for future growth.
To see Spark’s full report on KIDS stock, click here.
More about OrthoPediatrics
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. It has developed a comprehensive product offering to improve the lives of children with orthopedic conditions, covering trauma and deformity, scoliosis, and sports medicine. OrthoPediatrics markets over 80 products and distributes them in the United States and over 70 countries worldwide.
Average Trading Volume: 144,210
Technical Sentiment Signal: Sell
Current Market Cap: $505M
See more insights into KIDS stock on TipRanks’ Stock Analysis page.